National Comprehensive Cancer Network
- Educational Events & Programs
- NCCN Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™
- NCCN Annual Congress: Hematologic Malignancies™
- Regional Guidelines in Oncology Symposia
- NCCN Guidelines Update Webinar Series™
- State-of-the-Art Approaches to the Treatment of NSCLC
- NCCN Academy for Excellence & Leadership in Oncology™
- NCCN Resource Tool: REMS
- NCCN CME/CE Programs
- NCCN Oncology Case Management Program™
- NCCN International Programs
About the NCCN Clinical Practice Guidelines in Oncology™
Recent Updates to NCCN Clinical Practice Guidelines in Oncology™
NCCN Categories of Evidence and Consensus
NCCN Guidelines Steering Committee
Submission Request to the NCCN Guidelines Panels
NCCN Guidelines Panels-Meeting Schedule
Permissions Requests
NCCN Drugs & Biologics Compendium™
About the NCCN Drugs & Biologics Compendium™
Compendium Chapters
No Longer Recommended Uses
NCCN Chemotherapy Order Templates™
JNCCN – The Journal of the National Comprehensive Cancer Network
Subscribe Now
FAQ
JNCCN Task Force Supplements
Clinical Recommendations
| |
Commercial SupportThis Congress is supported by educational grants from Amgen, Bayer HealthCare Pharmaceuticals Inc., Bristol-Myers Squibb Company, Celgene Corporation, Cephalon Oncology, Eisai Inc., Genentech BioOncology, Genzyme Oncology, Merck Oncology, MGI PHARMA, INC., Millenium Pharmaceuticals, Inc., Novartis Oncology, Ortho Biotech, Pharmion Corporation, and sanofi-aventis U.S. No personal information is provided to any grant providers. |
E-mail
Print
Mark
|
|
|
|
|
|
|
||